Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Liabilities and Shareholders Equity: 2022

Historic Liabilities and Shareholders Equity for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $321.9 million.

  • Therapeutics' Liabilities and Shareholders Equity fell 20.49% to $266.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.2 billion, marking a year-over-year change of. This contributed to the annual value of $321.9 million for FY2022, which is N/A change from last year.
  • Per Therapeutics' latest filing, its Liabilities and Shareholders Equity stood at $321.9 million for FY2022.
  • In the past 5 years, Therapeutics' Liabilities and Shareholders Equity ranged from a high of $321.9 million in FY2022 and a low of $321.9 million during FY2022.
  • Over the past 1 years, Therapeutics' median Liabilities and Shareholders Equity value was $321.9 million (recorded in 2022), while the average stood at $321.9 million.